Skip to main content
Hyper Corporation Inc. logo

Hyper Corporation Inc. — Investor Relations & Filings

Ticker · 065650 ISIN · KR7065650004 KO Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Filings indexed 391 across all filing types
Latest filing 2022-12-15 Capital/Financing Update
Country KR South Korea
Listing KO 065650

About Hyper Corporation Inc.

https://hyper-corp.com/

Hyper Corporation Inc. is a company transitioning from a clinical-stage biopharmaceutical firm to a new-tech-based platform provider. Its core Bio & Healthcare division develops treatments and diagnostic technologies for neurodegenerative diseases like Alzheimer's, aiming to build a comprehensive digital senior healthcare platform. The company is expanding by integrating AI and blockchain technologies into new sectors. Its IP & Content division focuses on securing intellectual property and innovating content distribution, while its New Tech division develops platforms to connect online and offline services. This strategy fuses its biotechnology expertise with advanced IT to create new business models and services.

Recent filings

Filing Released Lang Actions
전환사채(해외전환사채포함)발행후만기전사채취득
Capital/Financing Update Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) regarding the acquisition of convertible bonds before maturity by the issuer (Medifron). This type of filing, which details changes in capital structure and debt obligations, falls under the 'Capital/Financing Update' category as it relates to the company's financing activities and debt management.
2022-12-15 Korean
증권발행결과(자율공시)
Share Issue/Capital Change Classification · 100% confidence The document is a formal announcement regarding the results of a securities issuance (specifically a third-party capital increase/private placement). It details the number of shares issued, the total amount raised, and the payment date. This falls under the category of share issuance and capital changes.
2022-12-14 Korean
[기재정정]주요사항보고서(유상증자결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) regarding a 'Decision on Paid-in Capital Increase' (유상증자결정). It details the amendment of terms for a third-party capital increase, including changes to the number of shares, payment dates, and listing dates. This falls under the category of capital structure changes and financing activities.
2022-11-29 Korean
전환가액의조정
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing from the Korean Exchange (KRX) system regarding the adjustment of the conversion price for convertible bonds (CB). It details the change in conversion price, the number of convertible shares, and the underlying calculation methodology due to market price fluctuations. This falls under capital structure changes and financing updates, specifically related to convertible debt instruments, which is best classified as 'Capital/Financing Update' (CAP).
2022-11-24 Korean
분기보고서 (2022.09)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the company Medifron DBT, covering the period from January 1, 2022, to September 30, 2022. It contains detailed financial statements, management discussion and analysis, and corporate governance information, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2022
2022-11-14 Korean
전환가액의조정
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing from Medifron regarding the adjustment of the conversion price of convertible preferred shares due to a decline in market price. This type of disclosure, which details changes to capital structure instruments (convertible securities), falls under the category of Capital/Financing Update (CAP).
2022-10-05 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.